Nektar R&D Chief Sells Shares on Rule 10b5‑1 Plan, Signals Routine Liquidity Management amid Ongoing Insider Buying Wave
Insightful Nektar insider‑sale analysis: what Jonathan Zalevsky’s Rule 10b5‑1 trade means for shareholders and long‑term confidence in the biotech pipeline.
4 minutes to read